I think the right bit of news and it will smash through 17.5 cents.
SCE haven't done an update on last OXY trial and KINGS sale at $3.6 Billion to Pfizer.
Even at a discounted valuation of just 10 percent that is still 50 cents per share. Just for OXY and Morphein.
They already from last update have a 49 cents to $1.03 valuation.
The results of the OXY trial and the KING deal add much weight.
PoS
another run at 17.5, page-16
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(25.0%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.258K | 419.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 33149783 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 35370246 | 20 |
View Market Depth
| Last trade - 10.00am 09/10/2024 (20 minute delay) ? |
| AVE (ASX) Chart |